The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
Ramirez was testifying in support of House Bill 1152, a proposal in the Washington Legislature to require gun owners to lock ...
Kennedy repeatedly refused to acknowledge scientific consensus that childhood vaccines don’t cause autism and that COVID-19 ...
RFK Jr.'s dismissal of vaccine science during Senate hearings raises concerns about his fitness for HHS secretary role.
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
The message reiterated an offer for a chance to take a second job or travel to a “dream destination” and remain on the ...